Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James E. Flynn currently holds 8,299,225 shares of Talon Therapeutics, Inc. (TLON.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James E. Flynn has been a net buyer of TLON.OB stock. They have purchased $154.3M and sold $133.4M worth of shares.
James E. Flynn's most recent insider trade was on Nov 24, 2025, when they sold 371,287 shares at $95.45 per share.
James E. Flynn serves as Executive at Talon Therapeutics, Inc. (TLON.OB). They have executed 331 insider transactions totaling $287.6M over their tenure at the company.
James E. Flynn holds the position of Executive at Talon Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
James E. Flynn has shown a buying trading pattern, with $154.3M in total purchases and $133.4M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by James E. Flynn was on Jun 8, 2021, when they purchased $96.0M worth of CMAX shares. This transaction involved 9,600,000 shares at $10.00 per share.
James E. Flynn currently owns 8,299,225 shares of Talon Therapeutics, Inc. (TLON.OB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James E. Flynn's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James E. Flynn has 331 Form 4 filings on record as an insider at Talon Therapeutics, Inc..
Set alerts for James E. Flynn and 40,000+ other insiders.